Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 0.42 |
| ▸ | CA1 | P00915 | 15/20 | 0.42 |
| ▸ | CA9 | Q16790 | 12/20 | 0.42 |
| ▸ | CA12 | O43570 | 9/20 | 0.42 |
| ▸ | CA7 | P43166 | 6/20 | 0.42 |
| ▸ | CA4 | P22748 | 5/20 | 0.42 |
| ▸ | CA5A | P35218 | 5/20 | 0.42 |
| ▸ | CA6 | P23280 | 4/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.42 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150811 | 0.80 | HTR6 (0.38) | CA2CA1CA9CA5A | |
| SCHEMBL8387010 | 0.78 | HTR6 (0.31) | CA2CA1CA9CA5A | |
| SCHEMBL1726647 | 0.76 | — | — | |
| SCHEMBL6135776 | 0.76 | — | — | |
| SCHEMBL219484 | 0.76 | TSHR (0.42) | CA2CA1LMNA | |
| SCHEMBL77668 | 0.76 | PTGS2 (0.33) | — | |
| SCHEMBL600073 | 0.76 | ALDH1A1 (0.42) | — | |
| SCHEMBL1727931 | 0.76 | ELANE (0.38) | — | |
| SCHEMBL1727551 | 0.76 | — | — | |
| SCHEMBL4687573 | 0.74 | CA2 (0.39) | CA2CA1CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2484 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024133860-A1 | SYNTHESIS OF SMALL MOLECULE AGONISTS OF NEUROPTROPHIN | Oculis Operations Sàrl (CH) | 2024-06-27 | — | — | WO | claimed |
| US-20230331715-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2023-10-19 | — | — | US | claimed |
| EP-4251615-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2023-10-04 | — | — | EP | claimed |
| CN-116406362-A | Spiro [3.3] heptane derivatives for the treatment and prevention of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2023-07-07 | — | — | CN | claimed |
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | Shenzhen Bay Laboratory (CN) | 2023-05-25 | — | — | US | claimed |
| EP-4151621-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Bay Laboratory (CN) | 2023-03-22 | — | — | EP | claimed |
| US-20220387385-A1 | NEW TREATMENT REGIMENT FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS | ACCURE THERAPEUTICS, S.L. (ES) | 2022-12-08 | — | — | US | claimed |
| CN-115052595-A | Novel therapeutic methods for treating neurological diseases or disorders | 阿库尔疗法公司 | 2022-09-13 | — | — | CN | claimed |
| WO-2022112188-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2022-06-02 | — | — | WO | claimed |
| EP-3993784-A1 | COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS | Accure Therapeutics, S.L. (ES) | 2022-05-11 | — | — | EP | claimed |
| US-4283556-A | Process for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzene | TOMS RIVER CHEMICAL CORPORATION (US) | 1981-08-11 | — | — | US | claimed |
| US-4275201-A | Aryl substituted diketones | STERLING DRUG INC. (US) | 1981-06-23 | — | — | US | claimed |
| US-4247479-A | REACTING THE OXIME HYDROCHLORIDE WITH THREE MOLES OF ACETIC ANHYDRIDE | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-27 | — | — | US | claimed |
| US-4246284-A | Aminosulfonyl-substituted aryloxyalkyl diketones | STERLING DRUG INC. (US) | 1981-01-20 | — | — | US | claimed |
| EP-0011048-A1 | A process for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzene | Toms River Chemical Corporation (US) | 1980-05-14 | — | — | EP | claimed |
| US-RE29358-E | ANTI-MALARIA AND ANTI-TUBERCULOSIS AGENTS | AMERICAN CYANAMID COMPANY (US) | 1977-08-16 | — | — | US | claimed |
| US-4024123-A | TEXTILES | DUSSY PAUL | 1977-05-17 | — | — | US | claimed |
| US-4001204-A | Magenta image-providing phenylazonaphthyl dues containing a morpholinyl of piperidine radical | EASTMAN KODAK COMPANY (US) | 1977-01-04 | — | — | US | claimed |
| US-3954476-A | Diffusable dye-releasing compounds which are cleavable upon oxidation | EASTMAN KODAK COMPANY (US) | 1976-05-04 | — | — | US | claimed |
| US-3932380-A | DIFFUSION TRANSFER COLOR PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1976-01-13 | — | — | US | claimed |